Reviewing Pervasip (OTCMKTS:PVSP) and NextPlat (NASDAQ:NXPL)

Valuation & Earnings

This table compares Pervasip and NextPlat”s gross revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Pervasip $15.77 million 0.10 -$2.35 million N/A N/A
NextPlat $37.76 million 0.57 -$3.78 million ($0.29) -3.93

Pervasip has higher earnings, but lower revenue than NextPlat.

Risk & Volatility

Pervasip has a beta of -0.22, indicating that its share price is 122% less volatile than the S&P 500. Comparatively, NextPlat has a beta of 0.92, indicating that its share price is 8% less volatile than the S&P 500.

Profitability

This table compares Pervasip and NextPlat’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Pervasip -16.98% N/A -20.89%
NextPlat -7.59% 29.57% 21.73%

Institutional & Insider Ownership

1.3% of NextPlat shares are owned by institutional investors. 9.2% of Pervasip shares are owned by company insiders. Comparatively, 49.9% of NextPlat shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

NextPlat beats Pervasip on 8 of the 9 factors compared between the two stocks.

About Pervasip

(Get Free Report)

Pervasip Corporation focuses on developing cloud-based applications to monitor and control greenhouse facilities. It intends to develop and deliver products and technologies to agricultural markets; develop scientific methods for the analysis of cannabinoids in flowers, concentrates, and edibles; and assist medical marijuana specialty production facilities to regulate, calculate proper dosage, and understand the importance of consistency in product. The company was formerly known as eLEC Communications Corp. and changed its name to Pervasip Corp. in December 2007. Pervasip Corp. was founded in 1964 and is based in White Plains, New York.

About NextPlat

(Get Free Report)

NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities. It also offers COVID-19 related diagnostics and vaccinations, and medication adherence packaging; and value-added services, such as prior authorization assistance, same-day home-medication delivery, on site provider consultation services, primary care reporting and analytics, and customized packaging solutions, as well as acquires and leases an e-commerce platform to collaborate with businesses to optimize their ability to sell their goods online. In addition, it operates e-commerce websites, as well as third-party e-commerce storefronts that provides mobile satellite services solutions for satellite-enabled voice, data, personnel and asset tracking, machine-to-machine, and internet of things connectivity services; voice, data communications, internet of things (IoT), and machine-to-machine services; tracking and monitoring solutions and services; satellite communications products; and GPS enabled emergency locator distress beacons. Further, it offers satellite tracking devices used to monitor the location, movements, and history of anything that moves; SolarTrack, a compact, lightweight, IoT tracking device powered by the sun; and GTCTrack, a subscription-based mapping and tracking portal. The company was formerly known as Orbsat Corp. and changed its name to NextPlat Corp in January 2022. NextPlat Corp is based in Coconut Grove, Florida.

Receive News & Ratings for Pervasip Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pervasip and related companies with MarketBeat.com's FREE daily email newsletter.